期刊文献+

阿奇霉素缓释微丸体外释药影响因素考察 被引量:3

Factors influencing in vitro release of azithromycin from Sustained-release pellets
下载PDF
导出
摘要 目的 考察影响阿奇霉素缓释微丸体外释药的各种因素,为阿奇霉素缓释制剂的研制提供实验依据。方法 选用微晶纤维素为空白丸芯,将阿奇霉素制成缓释微丸,通过测定体外释放度,考察EC粘度及增重、致孔剂用量、释放介质pH值对阿奇霉素缓释微丸体外释药速率的影响。结果 EC粘度、包衣增重、致孔剂用量、释放介质pH值对释药速率有显著影响。结论 选用适宜包衣材料及致孔剂,调节包衣增重,可制备具有理想释药行为的阿奇霉素缓释微丸。 OBJECTIVE To investigate the impact of the in vitro release of azithromycin sustained-release pel- lets of various factors,and provide experimental basis for the development of azithromyein sustained-release formula- tions. METHODS Azithromyein was made to sustained-release pellets,with microerystalline cellulose as blank pill core. The in vitro release was measured to investigate the effect of EC viscosity, weight gain and poreforming agents dosage and the release medium pH on release rate in vitro. RESULTS EC viscosity, weight gain, pore-forming a- able coating material and pore-forming agents, adjust coating weight can prepare the desired release behavior of az- ithromyein sustained-release pellets.
出处 《海峡药学》 2013年第7期26-28,共3页 Strait Pharmaceutical Journal
关键词 阿奇霉素 体外 释药速率 Azithromyein In vitro Release rate
  • 相关文献

参考文献3

二级参考文献21

  • 1FDA批准阿奇霉素缓释型口服混悬剂[J].世界临床药物,2005,26(8):449-449. 被引量:1
  • 2卢美菊.阿奇霉素与红霉素随机对照治疗呼吸道感染的临床疗效[J].安徽医药,2006,10(4):259-260. 被引量:2
  • 3[3]Liu P,Allaudeen H,Chandra R,et al.Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen[J].Antimicrob Agents Chemother,2007,51(1):103-109.
  • 4[4]Chandra R,Liu P,Breen JD,et al.Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin[J].Clin Pharmacokinet,2007,46(3):247-259.
  • 5[5]Blumer JL.Evolution of a new drug formulation:the rationale for high-dose,short-course therapy with azithromycin[J].Int J Antimicrob Agents,2005,26(Suppl 3):S143-147.
  • 6[6]Hadley JA.Value of short-course antimicrobial therapy in acute bacterial rhinosinusitis[J].Int J Antimicrob Agents,2005,26(Suppl 3):S164-169.
  • 7[7]Girard D,Finegan SM,Dunne MW,et al.Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models[J].J Antimicrob Chemother,2005,56(2):365-371.
  • 8[8]Blanco M,Valdes D,Llorente I,et al.Application of NIR Spectroscopy in polymorphic analysis:study of pseudo-polymorphs stability[J].J Pharm Sci,2005,94(6):1336-1342.
  • 9[9]Gandhi R,Pillai O,Thilagavathi R,et al.Characterization of Azithromycin hydrates[J].Eur J Pharm Sci,2002,16(3):175-184.
  • 10[10]Drehobl MA,De Salvo MC,Lewis DE,et al.Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults[J].Chest,2005,128(4):2230-2237.

共引文献2

同被引文献29

  • 1SAGARIKA BOSE, ROBIN H. Bogner. Solventless Pharma-ceutical Coating Processes:A Review [J]. Pharmaceutical De-velopment and Technology,2007,12(2) :115-131.
  • 2S DHUPPE,S S MITKARE,D M SAKARKAR. Recent Tech-niques of Pharmaceutical Solvent less Costing: A review [J].International journal of pharmaceutical sciences and research,2012,3(7);1976-1986.
  • 3DOROTHEA SAUER, MATTEO CEREA, JAMES DINU-NAIO’et al. Dry powder coating of pharmaceuticals : A review[J]. International Journal of Pharmaceutics, 2013 , 457 ( 2 ):488-502.
  • 4CAO QR,LIU Y’XUWJ,et al. Enhanced oral bioavailabilityof novel mucoadhesive pellets containing valsartan preparedby a dry powder-coating technique [J]. International Journalof Pharmaceutics, 2012 ,434(1-2) : 325-333.
  • 5SIMON ENSSLIN, KLAUS PETER MOLL, KURT PAU-LUS,et al. New insight into modified release pellets-Internalstructure and drug release mechanism [J]. Journal of Con-trolled Release.2008,128(2) :149-156.
  • 6GAQ C’HVANG J,JIAO Y,et al. In vitro release and in vi-vo absorption in beagle dogs of meloxicam from Eudragit FS30 D-coated pellets [J]. International Journal of Pharmaceu-tics,2006 ,322(1-2) : 104-112.
  • 7关世侠,杨民,李海刚.头孢呋辛酯掩味微丸的制备[J].中国药房,2008,19(22):1723-1724. 被引量:4
  • 8王敬敏,孙进.缓控释包衣技术及聚合物包衣材料的应用进展[J].中南药学,2013,11(8):583-587. 被引量:8
  • 9张安萍,姜建国,张佳,糜志远.吉非替尼微丸胶囊的研制[J].中国医药工业杂志,2013,44(11):1123-1126. 被引量:2
  • 10对乙酰氨基酚颗粒采用乙基纤维素水分散体(苏丽丝~)进行掩味包衣的研究[J].中国医药工业杂志,2014,45(7). 被引量:1

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部